English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

Stojdl, D., Lichty BD, tenOever BR, Paterson JM, Power, A., Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott, J., & Bell, J. (2003). VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell, 3(3), 263–275. doi:10.1016/S1535-6108(03)00241-1.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-0013-DB2F-6 Version Permalink: http://hdl.handle.net/11858/00-001M-0000-0013-DB30-D
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Stojdl, DF, Author
Lichty BD, tenOever BR, Paterson JM, Power, A1, Author              
Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, Brown EG, Durbin RK, Durbin JE, Hiscott, J, Author
Bell, JC, Author
Affiliations:
1Department Physiology of Cognitive Processes, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497798              

Content

show
hide
Free keywords: -
 Abstract: Ideally, an oncolytic virus will replicate preferentially in malignant cells, have the ability to treat disseminated metastases, and ultimately be cleared by the patient. Here we present evidence that the attenuated vesicular stomatitis strains, AV1 and AV2, embody all of these traits. We uncover the mechanism by which these mutants are selectively attenuated in interferon-responsive cells while remaining highly lytic in 80 of human tumor cell lines tested. AV1 and AV2 were tested in a xenograft model of human ovarian cancer and in an immune competent mouse model of metastatic colon cancer. While highly attenuated for growth in normal mice, both AV1 and AV2 effected complete and durable cures in the majority of treated animals when delivered systemically.

Details

show
hide
Language(s):
 Dates: 2003-10
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: URI: http://www.sciencedirect.com/science/article/pii/S1535610803002411
DOI: 10.1016/S1535-6108(03)00241-1
BibTex Citekey: StojdlLtPPKMRPABDDHB2003
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cancer Cell
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 3 (3) Sequence Number: - Start / End Page: 263–275 Identifier: -